Peptide Discovery
Delivering Peptide Discovery Solutions
Learn More
What We Do
Orbit Discovery provides peptide discovery services for therapeutic applications, including radionuclide targeting, nucleic acid targeting, targeted protein degradation, soluble protein targeting and GPCR agonism and antagonism.

We combine our bead-based display system and microfluidics to perform high-throughput screening across very large chemical spaces.

Our services are customizable for both affinity screening (targeting binders) and direct functional screening (especially for agonism and antagonism) using proprietary reporter cell lines.

Our mission is to help partners identify peptide therapeutic hits through advanced high-throughput affinity and functional screening techniques.

The Orbit Display Bead:
Peptide and Encoding DNA: Linked

Applications
Our Platform
Learn More

Latest Updates

Orbit Discovery to attend the 2024 European Peptide Symposium
July 15, 2024

Simon Bushell, will be attending the 37th European Peptide Symposium, to be held in August in Florence, Italy. This year the event is merged with the 14th International Peptide Symposium, and promises to be the biggest peptide event of the year.

Orbit Discovery to attend the 2024 Boulder Peptide Symposium
July 12, 2024

The Boulder Peptide Symposium continues to be the premier peptide discovery and development meeting of the year. Orbit Discovery will again be attending this year's event in September.

Orbit Discovery to attend 3rd Annual Targeted Radiopharmaceuticals Summit
July 10, 2024

Orbit Discovery CEO, Neil Butt, will be attending the 3rd Annual Targeted Radiopharmaceuticals Summit in San Diego, CA from July 30th to August 1st.

Work With Us
Orbit Discovery work with Big Pharma and
Small Biotechs alike.

Find out how Orbit Discovery can help with your peptide discovery needs
Contact Us